Go Unlimited with Magzter GOLD
Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just
Try GOLD - Free
Leveraging Microfluidic Technology for mRNA-LNP Manufacturing
Express Pharma
|January 2026
Over the past five years, messenger RNA (mRNA) therapeutics have undergone a rapid transition from experimental tools to powerful, life-saving medicines. From vaccines to cancer immunotherapies, mRNA offers the ability to instruct our own cells to produce therapeutic proteins on demand.
-
Yet, behind this biological revolution lies a critical engineering challenge - how to deliver the fragile mRNA safely, efficiently, and reproducibly into cells. The answer lies in lipid nanoparticles (LNPs), tiny lipid-based carriers that protect mRNA molecules ensuring efficient cellular uptake. However, as the field races from lab-scale discovery to global commercialization, traditional manufacturing methods for LNPs are proving to be a bottleneck. The next leap forward in scalable, precise, and reproducible LNP production is being driven by microfluidic technology.
Why LNPs Matter?
LNPs are the unsung heroes of the mRNA revolution. They form protective lipid shells around mRNA strands, shielding them from degradation and facilitating delivery into target cells. Their composition; typically, ionizable lipids, cholesterol, phospholipids, and PEG-lipids, must be carefully balanced to ensure stability, efficiency, and biocompatibility (1). Even small variations in formulation can significantly impact potency and safety.
Microfluidics: Precision at the Microscale
This story is from the January 2026 edition of Express Pharma.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Express Pharma
Express Pharma
NAVIGATING AVUCA WORLD
From supply disruptions to rising operational uncertainty, geopolitics is reshaping the pharma landscape. Experts discuss what it will take for organisations to stay resilient and future-ready
3 mins
June 2026
Express Pharma
Quality under pressure: Strengthening continuity amid geopolitical uncertainty
One of the most persistent risks facing Indian pharma manufacturers is the industry's heavy dependence on China for KSMs and APIs. For decades, this arrangement offered cost advantages that were difficult to resist. Today, however, that dependence is being exposed as a serious quality liability, cautions
8 mins
June 2026
Express Pharma
Ecocool®: A next-generation cooling agent for advanced formulations
Ecocool® supports patient-centric oral formulations with sustained cooling, taste masking and compatibility across multiple dosage forms to improve palatability and compliance.
3 mins
June 2026
Express Pharma
OPTIMA India: Growth and commitment to the market
India is one of the fastest-growing pharmaceutical markets worldwide and is increasingly becoming a hub of innovation for biosimilars, injectables, cell and gene, ADC’s and complex biologics.
3 mins
June 2026
Express Pharma
Indian Pharmacopoeia 2026: Raising the bar for quality standards of medicines
Abdul Nazar K, Government Analyst, Kerala, Expert Working Group member of the Indian Pharmacopoeia Commission (IPC), and Research Scholar at the Faculty of Public Health, SRIHER, Chennai, examines the significance of the Indian Pharmacopoeia 2026 and highlights how the latest edition aligns Indian pharmaceutical benchmarks with global standards
4 mins
June 2026
Express Pharma
Ensuring pharma compliance with testo data measurement technology
Testo highlights the importance of end-to-end climate monitoring, data compliance, and calibration systems in helping pharmaceutical companies maintain controlled storage, transport, and production environments for medicines, vaccines, laboratory samples, and blood products
3 mins
June 2026
Express Pharma
Financial strategies for uncertain times
Inspite of current geopolitical disruptions, both larger pharma enterprises and smaller promoter-driven entities are playing for the long term, balancing near-term financial prudence while laying the foundation for measured, even aggressive, future bets
7 mins
June 2026
Express Pharma
The winds reshaping Indian pharma supply chains
As the era of hyper-globalisation appears to have run its course,with geopolitics increasingly shaping geoeconomics, Indian pharma supply chains are being forced to rethink resilience, adapt to disruption, and prepare for a far more unpredictable global environment
9 mins
June 2026
Express Pharma
Indore Pharma Summit: Mapping the future of India pharma
From AI and smart manufacturing to sustainability, quality culture, faster drug development, and CDMO opportunities, the summit highlighted how India’s pharma industry is preparing for a more innovation-led and globally competitive future.
10 mins
June 2026
Express Pharma
PROSOLV® SMCC 50 - A high-functional excipient from JRS Pharma
The development of co-processed, multi-functional excipients has enabled formulators to address multiple challenges with a single excipient, resulting in enhanced production and better finished product quality.
3 mins
June 2026
Listen
Translate
Change font size